Cipla Limited has launched a first-of-its-kind Sputum Inflammometry Lab at the Breathefree Lung Wellness Center (BLWC) in Mumbai, marking the advancement of precision respiratory diagnostics and integrated respiratory care in the country.

The lab was inaugurated by Dr. Parameswaran Nair, globally recognised as one of the pioneers and leading experts in the field of Sputum Inflammometry. The inauguration took place in the presence of 15 eminent pulmonologists and respiratory experts from leading institutes across India.

Sputum inflammometry is an advanced diagnostic approach that assesses airway inflammation in patients with chronic respiratory conditions such as severe asthma, chronic obstructive pulmonary disease (COPD), and bronchiectasis. 

Dr Jaideep Gogtay, Global Chief Medical Officer, Cipla Limited said, “Chronic respiratory diseases are increasingly complex and heterogeneous in nature, making accurate assessment of airway inflammation critical for optimal disease management." 

“Sputum Inflammometry has transformed the understanding and management of airway diseases globally by enabling clinicians to identify specific inflammatory phenotypes and tailor therapy accordingly. This advanced capability can now play an important role in improving respiratory care and advancing clinical research in India,” added Dr Gogtay.